drugset / Trial / NCT00229437
Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of TAK-128, once daily (QD), in treating subjects with diabetic peripheral neuropathy.
Timeline
- Start
- 2005-03
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sapanisertib | Small molecule | 5 mg | Oral |
| Subject | Sapanisertib | Small molecule | 50 mg | Oral |
| Subject | Sapanisertib | Small molecule | 100 mg | Oral |